Innovating Works
Mostrando 1 al 20 de 99 resultados
MAP-ID: Multilevel approaches to understanding chronic inflammatory diseases. The MAP-ID project aims to deliver an East-West Europe-integrating training programme for PhD students, focused on tackling one of the most...
2024-08-29 - 2030-03-31 | Financiado
UMBRELLA: Unleashing a CoMprehensive Holistic and Patient Centric Stroke Management for a Better Rapid Adva... "UMBRELLA is a holistic approach to progress, reshape, and benchmark the overall stroke care pathway and set new and improved standards of c...
2024-07-31 - 2029-09-30 | Financiado
PIECES: TOWARDS LARGE SCALE ADAPTION AND TAILORED IMPLEMENTATION OF EVIDENCE BASED PRIMARY CANCER PREVENTION... INSTITUT CATALA D'ONCOLOGIA tramitó un HORIZON EUROPE: HORIZON-MISS-2022-CANCER-01 The high and growing global burden of cancer urges the need for effective implementation of primary cancer prevention (PCP) programmes targe...
2023-04-24 - 2027-05-31 | Financiado
Bootstrap: Boosting Societal Adaptation and Mental Health in a Rapidly Digitalizing Post Pandemic Europe INSTITUT CATALA DE LA SALUT tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-two-stage BACKGROUND: Adolescents are at particularly high risk for digital technology overuse, including in response to the COVID pandemic, and are t...
2023-04-21 - 2028-06-30 | Financiado
eprObes: Preventing lifetime obesity by early risk factor identification prognosis and intervention CENTRO DE INVESTIGACION BIOMEDICA EN RED CIBER tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-STAYHLTH-01-two-stage Obesity is one of the main population health threats worldwide, with a sustained increase in prevalence over the last decades and a constell...
2023-04-11 - 2028-04-30 | Financiado
MELCAYA: Novel health care strategies for melanoma in children adolescents and young adults FUNDACIO CLINIC PER A LA RECERCA BIOMEDICA tramitó un HORIZON EUROPE: HORIZON-MISS-2021-CANCER-02 "In childhood, adolescence and young adults (CAYA), melanoma is under-studied and non-existing tailored clinical guidelines and standardized...
2022-12-01 - 2026-11-30 | Financiado
HORUS: Casting light on HOst-cytomegaloviRUs interaction in Solid organ transplantation UNIVERSITE DE BORDEAUX tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 "Solid organ transplantation (SOT) is the treatment of choice for end-stage organ failure but the immunosuppressive drugs used to prevent gr...
2022-05-30 - 2027-10-31 | Financiado
UNDINE: The human genetic and immunological determinants of the clinical manifestations of SARS-CoV-2 infect... AARHUS UNIVERSITET tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 "The consequences of SARS-CoV-2 exposure range from a lack of infection to lethal COVID-19. This immense inter-individual clinical variabili...
2022-05-20 - 2026-05-31 | Financiado
COVend: Biomarker and AI-supported FX06 therapy to prevent progression from mild and moderate to severe stag... JOHANN WOLFGANG GOETHEUNIVERSITAET FRANKFURT AM MAIN tramitó un HORIZON EUROPE: HORIZON-HLTH-2021-CORONA-01 More than 2.7 million hospitalisations of COVID-19-infected patients have occurred in Europe alone since the outbreak of the coronavirus in...
2021-11-12 - 2025-01-31 | Financiado
NEUROSTAD: Characterization of the gene and protein networks regulated by Staufen 2 in neurogenesis and their a... FUNDACIO INSTITUT D?INVESTIGACIO BIOMEDICA DE BELLVITGE (IDIBELL) tramitó un H2020: H2020-MSCA-IF-2020 Neurogenesis is a crucial process by which new neurons are formed in the brain through the conversion of Neuronal stem cells (NPCs). Altered...
2021-04-20 - 2023-10-12 | Financiado
PhyCaR: Pseudohypoxia mediated cardiac regeneration FUNDACIO INSTITUT D?INVESTIGACIO BIOMEDICA DE BELLVITGE (IDIBELL) tramitó un H2020: H2020-MSCA-IF-2020 Ischemic heart disease is the main cause of death in Europe and the world, and its main manifestation is myocardial infarction (MI). The MI...
2021-04-12 - 2024-02-13 | Financiado
STEMCEDIF: Polymeric cell laden vascular graft for blood vessel mimicking in tissue engineering applications FUNDACIO INSTITUT D?INVESTIGACIO BIOMEDICA DE BELLVITGE (IDIBELL) tramitó un H2020: H2020-MSCA-IF-2020 The aim of the interdisciplinary STEMCEDIF project is to produce polymeric cell-laden vascular grafts by 3D printing for their usage as a bi...
2021-04-12 - 2024-02-29 | Financiado
scGATA2track: Single cell tracking of malignant transformation in GATA2 deficiency FUNDACIO INSTITUT D?INVESTIGACIO BIOMEDICA DE BELLVITGE (IDIBELL) tramitó un H2020: H2020-MSCA-IF-2020 Precision medicine has improved overall survival of cancer patients; unfortunately, not all diseases can benefit from this practice due to a...
2021-03-18 - 2023-08-31 | Financiado
ReSinAge: Regeneration of Sinusoidal niches to preserve hematopoiesis after chemotherapy on Ageing FUNDACIO INSTITUT D?INVESTIGACIO BIOMEDICA DE BELLVITGE (IDIBELL) tramitó un H2020: ERC-2020-COG Cancer is a disease of the elderly and chemotherapy remains the mainstay of treatment. The benefits of chemotherapy include increased overal...
2021-02-16 - 2026-02-28 | Financiado
RESILIENCE: Remote Ischemic Conditioning in Lymphoma Patients Receiving Anthracyclines. CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CARLOS III FSP tramitó un H2020: H2020-SC1-BHC-2018-2020 The increasing life expectancy of the population and the development of effective therapies result in a growing population of aged cancer su...
2021-01-29 - 2026-05-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.